De Remediis is a peer-reviewed english-language open-access journal published by University of Debrecen, Faculty of Pharmacy in Hungary, operating under an open-access model since 2024. The journal covers Therapeutics. Pharmacology.
Authors publish in De Remediis without paying any article processing charge (APC) — making it a fully diamond/platinum open-access venue, supported entirely by its publisher or sponsor. Articles are released under the CC BY, Publisher's own license license (see other journals using this license).
To date, De Remediis has published 17 articles. Articles are minted with DOIs through the prefix 10.71116. All submissions undergo plagiarism screening before peer review.
Keywords
pharmaceutical technology, pharmaceutical chemistry, biopharmaceutics, pharmacology, pharmacognosy, cell biology
At a glance
- Country
- Hungary
- Primary language
- English
- License
- CC BY, Publisher's own license
- Peer review
- Anonymous peer review
- OA since
- 2024
- Review time
- 5 weeks
- DOI prefix
10.71116- Plagiarism check
- Yes
ISSN
- electronic
- 3058-0358
Frequently asked questions
Is De Remediis peer-reviewed?
Does De Remediis charge an article processing charge (APC)?
What subjects does De Remediis publish?
What languages does De Remediis accept?
What is the ISSN of De Remediis?
3058-0358 (electronic).